Top compounds associated with response to KDELR3


Feature Type Standardized
Nominal ANOVA
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.12 0.0002
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.16 0.0002
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.15 0.0002
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.15 0.0002
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0002
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA SN-38 CTRPv2 pan-cancer AAC -0.15 0.0003
mRNA MS-275 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA SCH-79797 CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA AZD6482 GDSC1000 pan-cancer AAC 0.16 0.0003
Download CSV